Charles Schwab Investment Management Inc. lifted its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 1.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,191,677 shares of the company’s stock after purchasing an additional 16,616 shares during the quarter. Charles Schwab Investment Management Inc. owned about 0.96% of Henry Schein worth $82,464,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also modified their holdings of the company. Versant Capital Management Inc raised its stake in shares of Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after purchasing an additional 335 shares in the last quarter. Venturi Wealth Management LLC raised its position in Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock worth $41,000 after acquiring an additional 569 shares in the last quarter. Quent Capital LLC raised its position in Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock worth $47,000 after acquiring an additional 323 shares in the last quarter. Smartleaf Asset Management LLC raised its position in Henry Schein by 23.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after acquiring an additional 143 shares in the last quarter. Finally, City State Bank bought a new stake in Henry Schein in the fourth quarter worth about $55,000. 96.62% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
Several brokerages have commented on HSIC. Wells Fargo & Company began coverage on shares of Henry Schein in a research report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price target on the stock. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and boosted their price target for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Jefferies Financial Group boosted their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Mizuho started coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price target on the stock. Finally, UBS Group cut their price objective on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, February 26th. Six investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Henry Schein currently has a consensus rating of “Moderate Buy” and a consensus price target of $81.10.
Henry Schein Trading Up 1.2 %
Shares of NASDAQ HSIC opened at $75.45 on Tuesday. The stock has a market cap of $9.37 billion, a price-to-earnings ratio of 31.05, a PEG ratio of 2.13 and a beta of 0.90. The business has a 50 day simple moving average of $74.57 and a 200 day simple moving average of $72.59. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.49. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.
Henry Schein (NASDAQ:HSIC – Get Free Report) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). The firm had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.66 EPS. On average, research analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Read More
- Five stocks we like better than Henry Schein
- What is the Australian Securities Exchange (ASX)
- How to Protect Your Portfolio When Inflation Is Rising
- ETF Screener: Uses and Step-by-Step Guide
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- 3 Healthcare Dividend Stocks to Buy
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.